Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Cardiopulmonary function |
Maximum oxygen uptake (VO2ml/min/kg) (Higher value indicate better cardiorespiratory capacity) |
0 -12 weeks |
|
Secondary |
Vascular function |
Aortic pulse wave velocity (PWV) (m/sec.) (Higher PWV value indicate worse vascular function) |
0-12 weeks |
|
Secondary |
Level of disease activity |
Disease activity score 28 (DAS28) (Range 0-10 where a higher score indicate worse disease activity) |
0-12 weeks |
|
Secondary |
Level of disease activity |
Disease activity score 28 (DAS28) (Range 0-10 where a higher score indicate worse disease activity) |
0-6 months |
|
Secondary |
Level of disease activity |
Disease activity score 28 (DAS28) (Range 0-10 where a higher score indicate worse disease activity) |
0-12 months |
|
Secondary |
Homeostatic model assessment of insulin resistance (HOMA IR) |
Measure of insulin resistance (fasting glucose (mmol/L) and fasting insulin (mIU/ L) will be combined to report HOMA IR |
0-12 weeks |
|
Secondary |
Glycosylation level of hemoglobin (HbA1c) |
Glycosylation level of hemoglobin (mmol/mol) |
0-12 weeks |
|
Secondary |
Level of blood lipids |
Levels of triglycerides (mmol/L), Level of high-density lipoprotein (HDL) (mmol/L), low-density lipoprotein (LDL) ( mmol/L), Total cholesterol (mmol/L ) |
0-12 weeks |
|
Secondary |
Erythrocyte Sedimentation Rate (ESR) |
Level of high sensitivity ESR (mm/h) (Higher score indicate higher inflammation) |
0-12 weeks |
|
Secondary |
Erythrocyte Sedimentation Rate (ESR) |
Level of high sensitivity ESR (mm/h) (Higher score indicate higher inflammation) |
0-6 months |
|
Secondary |
Erythrocyte Sedimentation Rate (ESR) |
Level of high sensitivity ESR (mm/h) (Higher score indicate higher inflammation) |
0-12 months |
|
Secondary |
C-Reactive Protein (CRP) |
Level of high sensitivity CRP (mg/L) (Higher score indicate higher inflammation) |
0-12 weeks |
|
Secondary |
C-Reactive Protein (CRP) |
Level of high sensitivity CRP (mg/L) (Higher score indicate higher inflammation) |
0-6 months |
|
Secondary |
C-Reactive Protein (CRP) |
Level of high sensitivity CRP (mg/L) (Higher score indicate higher inflammation) |
0-12 months |
|
Secondary |
Cytokine levels |
Interleukin-6 (pg/mL), interleukin-10 (pg/mL), tumour necrosis factor-alpha (pg/mL) |
0-12 weeks |
|
Secondary |
Muscle function of lower extremities |
The one minute sit-to-stand test (Higher numbers of complete rises indicate better muscle function in lower extremities) |
0-12 weeks |
|
Secondary |
Hand-grip force |
Hand-grip force is assessed with a dynamometer ( Higher value indicate better grip strength) |
0-12 weeks |
|
Secondary |
Self-reported physical activity |
Self-reported questionnaire of habitual physical activity during a typical week. Numbers of hours on low, moderate and high intensity is summed for each category (A minimum of 150 minutes on moderate intensity or 75 minutes on high intensity are equal to health enhancing physical activity according to World Health Organization guidelines) |
0-12 weeks |
|
Secondary |
Self-reported physical activity |
Self-reported questionnaire of habitual physical activity during a typical week. Numbers of hours on low, moderate and high intensity is summed for each category (A minimum of 150 minutes on moderate intensity or 75 minutes on high intensity are equal to health enhancing physical activity according to World Health Organization guidelines) |
0-6 months |
|
Secondary |
Self-reported physical activity |
Self-reported questionnaire of habitual physical activity during a typical week. Numbers of hours on low, moderate and high intensity is summed for each category (A minimum of 150 minutes on moderate intensity or 75 minutes on high intensity are equal to health enhancing physical activity according to World Health Organization guidelines) |
0-12 months |
|
Secondary |
Objective assessment of physical activity |
Accelerometer to assess habitual physical activity during a typical week. Total time of physical activity and physical activity pattern assessed as time spent at different physical activity intensity levels are obtained using the metabolic equivalent of task values (METS). (Higher METs value indicate higher physical activity level.) |
0-12 weeks |
|
Secondary |
Objective assessment of physical activity |
Accelerometer to assess habitual physical activity during a typical week. Total time of physical activity and physical activity pattern assessed as time spent at different physical activity intensity levels are obtained using the metabolic equivalent of task values (METS). (Higher METs value indicate higher physical activity level.) |
0-6 months |
|
Secondary |
Objective assessment of physical activity |
Accelerometer to assess habitual physical activity during a typical week. Total time of physical activity and physical activity pattern assessed as time spent at different physical activity intensity levels are obtained using the metabolic equivalent of task values (METS). (Higher METs value indicate higher physical activity level.) |
0-12 months |
|
Secondary |
Pain intensity |
Visual Analogue Scale (VAS) (0-100, Higher score indicate worse pain) |
0-12 weeks |
|
Secondary |
Pain intensity |
Visual Analogue Scale (VAS) (0-100, Higher score indicate worse pain) |
0-6 months |
|
Secondary |
Pain intensity |
Visual Analogue Scale (VAS) (0-100, Higher score indicate worse pain) |
0-12 months |
|
Secondary |
Global health |
Visual Analogue Scale (VAS) (0-100, Higher score indicate worse health) |
0-12 weeks |
|
Secondary |
Global health |
Visual Analogue Scale (VAS) (0-100, Higher score indicate worse health) |
0-6 months |
|
Secondary |
Global health |
Visual Analogue Scale (VAS) (0-100, Higher score indicate worse health) |
0-12 months |
|
Secondary |
Fatigue |
The Multiple Fatigue Inventory (MFI-20) (4-20 for each subscale, Higher score indicates a higher degree of fatigue |
0-12 weeks |
|
Secondary |
Fatigue |
The Multiple Fatigue Inventory (MFI-20) (4-20 for each subscale, Higher score indicates a higher degree of fatigue |
0-6 months |
|
Secondary |
Fatigue |
The Multiple Fatigue Inventory (MFI-20) (4-20 for each subscale, Higher score indicates a higher degree of fatigue |
0-12 months |
|
Secondary |
Sleep |
Pittsburgh Sleep Quality Index (0-21, Higher score indicate worse sleep quality). |
0-12 weeks |
|
Secondary |
Sleep |
Pittsburgh Sleep Quality Index (0-21, Higher score indicate worse sleep quality). |
0-6 months |
|
Secondary |
Sleep |
Pittsburgh Sleep Quality Index (0-21, Higher score indicate worse sleep quality). |
0-12 months |
|
Secondary |
Activity limitations |
Health Assessment Questionnaire (HAQ) (0-3, Higher score indicate worse activity limitations) |
0-12 weeks |
|
Secondary |
Activity limitations |
Health Assessment Questionnaire (HAQ) (0-3, Higher score indicate worse activity limitations) |
0-6 months |
|
Secondary |
Activity limitations |
Health Assessment Questionnaire (HAQ) (0-3, Higher score indicate worse activity limitations) |
0-12 months |
|
Secondary |
Attitude to exercise |
Exercise Health Beliefs questionnaire (20-100, Higher score represents stronger exercise health beliefs. |
0-12 weeks |
|
Secondary |
Attitude to exercise |
Exercise Health Beliefs questionnaire (20-100, Higher score represents stronger exercise health beliefs. |
0-6 moths |
|
Secondary |
Attitude to exercise |
Exercise Health Beliefs questionnaire (20-100, Higher score represents stronger exercise health beliefs. |
0-12 months |
|
Secondary |
Body compositions |
Weight and height will be combined to report Body mass index BMI kg/m2 (A higher score indicate higher relative weight) |
0-12 weeks |
|
Secondary |
Waist circumference |
Measured with a tape measure midway between the lower rib and iliac crest. (A waist measurement of 80 centimeters or more for women and 94 centimeters or more for men indicate increased risk for diseases related to overweight) |
0-12 weeks |
|